Evidence map›Paper›PMID 37669982›Full record

ArticleScientific reports2023

Parametric study and process modeling for metronidazole removal by rhombic dodecahedron ZIF-67 crystals.

Sajad Mazloomi, Ali Amarloei, Faeze Gholami, Gholam Ali Haghighat, Gagik Badalians Gholikandi, Heshmatollah Nourmoradi, Ali Akbar Mohammadi, Mehdi Fattahi, Binh Nguyen Le

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Sajad MazloomiBiotechnology and Medicinal Plants Research Center, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Ali AmarloeiDepartment of Environmental Health Engineering, School of Public Health, Ilam University of Medical Sciences, Ilam, Iran.
Faeze GholamiDepartment of Environmental Health Engineering, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
Gholam Ali HaghighatFaculty of Civil, Water and Environmental Engineering, Shahid Beheshti University, Tehran, Iran.
Gagik Badalians GholikandiFaculty of Civil, Water and Environmental Engineering, Shahid Beheshti University, Tehran, Iran.
Heshmatollah NourmoradiDepartment of Environmental Health Engineering, School of Public Health, Ilam University of Medical Sciences, Ilam, Iran.
Ali Akbar MohammadiDepartment of Environmental Health Engineering, Neyshabur University of Medical Sciences, Neyshabur, Iran. mohammadi.eng73@gmail.com.
Mehdi FattahiInstitute of Research and Development, Duy Tan University, Da Nang, Vietnam. mehdifattahi@duytan.edu.vn.
Binh Nguyen LeInstitute of Research and Development, Duy Tan University, Da Nang, Vietnam.
Medical University of Ilam · IRDuy Tan University · VNIran University of Medical Sciences · IRShahid Beheshti University · IRUniversity of Jiroft · IRUniversity of Neyshabur · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metronidazole (MNZ) is an extensively used antibiotic against bacterial infections for humans and farm animals. Prevention of antibiotics discharge is essential to prevent adverse environmental and health impacts. A member of metal-organic frameworks, zeolite imidazole framework-67 with cobalt sulfate precursor (ZIF-67-SO

Indexed as

Body FluidsMetronidazoleAdsorptionAnimalsAnimals, DomesticAnti-Bacterial AgentsHumansAnti-Bacterial AgentsMetronidazole

Identifiers

PMID37669982
PMCPMC10480145
OpenAlexW4386465494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.